Trial Profile
Duloxetine and escitalopram for treatment of hot flushes in breast cancer survivors.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Jun 2011
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary) ; Escitalopram (Primary)
- Indications Hot flashes; Menopausal syndrome
- Focus Therapeutic Use
- 30 Jun 2011 New trial record